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Parotid gland tumorsObjective: Salivary gland tumors are challenging as regards preoperative diagnosis. The
aim of our study was to highlight the value of multiphasic CT and contrast enhanced
dynamic MRI in characterization of benign and malignant parotid tumors as well as to
compare diagnostic accuracy of both modalities.
Patients and methods: Study group included 45 patients (54 lesions), 26 males and 19
females, their age ranged from 24 to 78 years. All patients underwent both CT and MRI
examinations. Time intensity (or attenuation) curve for each lesion is analyzed and com-
pared with the final post-operative pathology.
Results: Type of the curve on dynamic contrast enhanced MRI had high sensitivity, speci-
ficity, positive predictive, negative predictive values and accuracy in characterization of
benign and malignant parotid tumors (94.4%, 97.2%, 94.4%, 97.2%, and 96.3% respectively).
Also, curve analysis on multiphasic CT revealed similar high sensitivity, specificity, positive
predictive, negative predictive values and accuracy as compared to DCE-MRI (92.6%, 96.3%,
92.6%, 96.3%, and 95.1% respectively).
Conclusion: Both dynamic contrast enhanced MRI and multiphasic CT have comparable
high accuracy in characterizing the different histological types of parotid gland tumors.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Salivary gland tumors represent about 3% of head and
neck tumors. Approximately 70% of salivary gland tumors
occur in the parotid gland [1,2]. It is of great importance
to differentiate between benign and malignant tumors
for optimal surgical planning as superficial parotidectomy
is performed for benign tumors. On the other hand, totalparotidectomy with or without sacrifice of the facial nerve
branches is performed for malignant tumors [3].
Diagnosing malignant parotid tumors based on clinical
findings has its own limitations. Few symptoms, such as
facial palsy, predict malignancy. Mostly, both benign and
malignant parotid gland tumors grow slowly. So, preoper-
ative radiologic assessment plays the main role in surgical
planning by accurate determination of the nature and the
location of the tumor [4].
Parotid gland exhibits different histologic types and
subtypes of primary tumors. So, the management of its
tumors requires understanding of anatomic details and
pathology. Furthermore, appropriate surgical approach
requires also the determination of histologic subtype of
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risk of local recurrence when managed by enucleation is
about 2%, whereas, the risk for local recurrence is reported
to be about 85% in pleomorphic adenoma managed in the
same manner. Therefore, different surgical procedures are
used among not only benign but also malignant tumors [5].
Ultra-sonography as an initial evaluation is particularly
a valuable tool for assessing parotid gland lesions because
it is cheap, easy, and widely available. Its disadvantages
are; it is operator dependent, and of less value in deep par-
otid lobe and facial nerve evaluation [4].
Preoperative fine needle aspiration biopsy (FNAB)
proved to be reliable in the diagnosis of parotid tumors.
However, few lesions may be impossible to differentiate
by only FNAB [6]. Also, inflammatory lesions of the parotid
glands may mimic epithelial tumors at cytology because
desquamated cells commonly simulate the former [7]. In
addition, FNAB may be inconclusive due to deficient sam-
ple, small lesion size, or tumors of the deep parotid gland
lobe [8].
Static MR imaging of parotid tumors had shown some
suggestive characters; bright T2 signal and poly-
lobulations could suggest pleomorphic adenoma, low T2
signal and cystic spaces suggest Warthin tumor, while
malignant neoplasms may be suggested in the presence
of high-grade tumors with infiltrative margins. However,
these features alone cannot accurately characterize parotid
tumors [9].
The role of static MRI in characterization of parotid
gland tumors appears to be debatable, except for deep
infiltration of malignant masses. Time to peak enhance-
ment (TTP) and washout ratio (WR) obtained from time
intensity curves (TICs) at DCE-MRI are very valuable in
characterization of parotid gland tumors [10].
Several studies have evaluated the role of CT in differen-
tiating parotid gland tumors [11]. As regards multiphasic
CT, very few data on the percentage enhanced wash-out
ratios among pleomorphic adenomas, Warthin tumors
and malignant tumors have been analyzed [12].
The purpose of our study was to compare the diagnostic
accuracy of multiphasic CT examination with DCE-MRI in
characterization and differentiation of various histologic
types of parotid tumors (pleomorphic adenoma, Warthin
tumor and malignant tumors) as to our knowledge, there
are no data in the literature compared between these
specific imaging techniques.2. Patients and methods
2.1. Patient population
This study was approved by our institutional review
board, and informed patient consent was obtained before
participation in the study according to institutional and
native guidelines. This prospective study was performed
between February 2013 and December 2015. Sixty-five
patients were included in the study. Twenty patients were
excluded from all analysis; 5 due to missed final patholog-
ical diagnosis, 8 proved to have inflammatory lesions and 7
patients underwent only one modality of examination(either CT or MRI only). The final study group included
45 patients. They were 26 males and 19 females, their
age ranged from 24 to 78 years with mean age of
51.06 ± 11.48 years.
All patients (45) underwent both CT and MRI examina-
tion. All patients underwent complete clinical examina-
tion, history taking including drug administration,
routine serum creatinine evaluation and preliminary ultra-
sound examination. The final post-operative pathology
was the gold standard for diagnosis.2.2. Multi-phasic CT technique and image analysis
CT was done by a 64 row multi-slice volume scanner
‘Brilliance 64 CT scanner, Philips Healthcare, Best Nether-
lands’ with fixed technique of examination. For early
enhanced image (30 s), scanning began from skull base to
the thoracic inlet. For the non-enhanced and delayed-
enhanced images (90 s, 5 min), the scanning range was
limited to the parotid gland in order to decrease radiation
dose for the patient and not to compromise image quality.
Helical CT acquisition parameters; 5-mm slice thickness,
120 kVp, 200 mA, 7.5 mm/s table speed, 0.8-s rotation
time, pitch of 0.625, and 5 mm reconstruction interval in
pre- and postcontrast images during which patient held
their breath and stopped deglutition to obtain best image
quality.
First, a non-enhanced examination of the parotid gland
was done. Then 50–80 ml of non-ionic contrast material
was given intravenously at a rate of 2 ml/s using a power
injector. In all patients, the second, third, and fourth
images were obtained 30 s, 90 s, and 5 min after the start
of contrast material injection respectively. The images
were obtained with standard soft tissue settings (window
width 300 HU; window level 40 HU).
The images were transferred to a work-station and
reviewed by the radiologist. All images were evaluated in
each phase, and the mean density of the lesion was calcu-
lated in Hounsfield units using a region of interest (ROI)
that includes solid portion of the tumor. A standardized
ROI was used for all cases.
The ROI circle was made with adequate margin to avoid
partial volume effects. Necrotic, cystic, hemorrhagic com-
ponents, and calcification of the parotid gland lesions, were
excluded, if they were present. Necrosis was considered as
having attenuation value of water (20 HU to 20 HU) on
non-contrast enhanced CT. On the other hand, calcification
is defined as a region having attenuation value more than
120 HU on non-contrast enhanced CT. Density numbers
were recorded and averaged for data analysis. The CT num-
bers, for each lesion, in all phases were compared. A plot
representing the time-attenuation curve was constructed
for each lesion.
2.3. Dynamic contrast enhanced MRI technique and image
analysis
The study was performed on Philips Enginia 1.5 T MRI
scanner for all patients. Dedicated multichannel head and
neck coil has been used. First, pre-contrast scan was
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of gadopentetate dimeglumine (GD-DTPA) (Magnevist)
contrast agent. The following sequences are included in
MRI examination: Axial T1-turbo spin echo (TSE) without
Fat suppression, coronal T2-Turbo spin echo with fat sup-
pression, and axial as well as coronal T2 sequence without
fat suppression. Axial T1-weighted image (600/20/2) [TR/
TE/number of excitations]; field of view: 18 cm; matrix:
256  192; section thickness: 2 mm; section gap: 1 mm)
and T2-weighted image (4000/90/4); field of view:
18 cm; matrix: 256  256; section thickness: 2 mm; sec-
tion gap: 1 mm) images were acquired before contrast
administration.
A dynamic axial T1 fat suppressed fast-spoiled gradient
recalled sequence (10.4/2.3/1; flip angle: 30; field of view:
18 cm; matrix: 256  128; section thickness: 4 mm; sec-
tion gap: 1 mm) with total acquisition time of 300 s was
acquired during bolus injection (0.1 mmol/kg) of single
intravenous dose of contrast agent gadopentetate dimeglu-
mine (Magnevist) at a rate of 2.5 ml/s given via an auto-
matic injector followed by 20 ml saline flush. Sequential
images through the lesion were obtained in axial plane
and at different time intervals (at 30, 60, 90, 120, 150,
180, 240 and 300 s following injection). Following dynamic
acquisition, conventional postcontrast MR images are
acquired in axial, sagittal and coronal planes.
Multiphase dynamic images were transferred to Philips
extended work space (EWS) release 2.6 workstation and
then analyzed. We placed a ROI within an area of the
tumor that exhibited the greatest degree of early enhance-
ment on the dynamic scanning, (avoiding cystic parts,
necrosis, vessels, calcifications and hemorrhages). Time
signal intensity curve (TIC) in the ROI of each examinationFig. 1. TIC tumor type classifications qwas plotted. TIC parameters analyzed included TTP (time
to peak enhancement) and WR (washout ratio).
According to the TIC tumor classification described by
Yabuuchi et al. the parotid tumors are categorized into four
TIC types (Fig. 1): type A, time to peak more than 120 s
(this is considered a gradual enhancement); type B, time
to peak 120 s or less, with high washout ratio (P30%) (this
is considered early enhancement and high washout); type
C, time to peak 120 s or less, with low washout ratio (<30%)
(this is considered early enhancement and low washout);
and type D, flat (seen in markedly cystic tumors) [13]. All
MR imaging findings together with the tumor specific TIC
were correlated with the final histopathologic diagnosis.
Semi quantitative and quantitative assessment of the
DCE-MRI was done. Semi quantitative assessment was
done using TIC. Quantitative assessment was done by mea-
suring TTP and wash out rate values.
2.4. Statistical analysis
All data were collected, tabulated and statistically ana-
lyzed using SPSS 16.0. Continuous data are expressed as
mean ± SD & median (min, max), and the categorial data
are expressed as number (percentage). Continuous vari-
ables were checked for normality by using Shapiro-Wilk
test. Mann-Whitney U (MW) test was used to compare
two groups of non-normally distributed data and indepen-
dent t test for normally distributed data. Percent of catego-
rial variables were compared using the Chi-square (X2) test
and Fischer exact test. All tests were two tailed. P < 0.05
was considered statistically significant and P < 0.01 was
considered highly statistically significant. P > 0.05 was con-
sidered non-statistically significant.uoted from Yabuuchi et al. [13].
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This prospective study included 45 patients having par-
otid gland tumors with their age ranging from 24 to
78 years with mean age of 51.06 ± 11.48 years. They were
26 males and 19 females.
Forty five patients included 19 patients with pleomor-
phic adenoma, 14 patients withWarthin tumors, 3 patients
with muco-epidermoid carcinoma, 2 patients with acinic
cell carcinoma, 2 patients with carcinoma ex pleomorphic
adenoma, 3 patients with lymphoma, and 2 patients with
metastatic lesions.
Forty one patients had unilateral lesions, while four
patients had bilateral lesions (3 Warthin tumor and 1 lym-
phoma patients). Number of lesions detected in each patient
ranged from 1 to 3 lesions with a median of 1 lesion. Thirty
nine patients had single lesion, 3 patients had two lesions (1
Warthin tumor, 1 lymphoma, and 1 carcinoma ex pleomor-
phic adenoma patients) and three patients had three lesions
(all were Warthin tumor patients). The total number of
lesions detected was 54 lesions.
Regarding the parotid lobe involved, twenty five lesions
were located in the superficial lobe, twenty seven lesions
were located in both superficial and deep lobes, one lesion
was located in the deep lobe and one lesion was located in
a peri-parotid LN (Warthin tumor).
According to the final post-operative histopathologic
reports, this study included forty benign lesions and four-
teen malignant lesions.
Forty benign lesions included 19 pleomorphic adeno-
mas, 21 Warthin tumors. Fourteen malignant lesions
included 4 lymphomas, 3 muco-epidermoid carcinomas,
3 carcinoma ex pleomorphic adenomas, 2 acinic cell carci-
nomas, and 2 metastatic lesions.
Tables 1 and 2 demonstrate the distribution and the
number of the pathologic lesions in our study with their
corresponding curve type detected by multiphasic CT as
well as dynamic contrast enhanced MRI study.Table 1
Multi-phasic CT time attenuation curve type detected in different parotid tumors.
Pathology No. of lesions on CT
Pleomorphic adenoma 19
Warthin Tumor 21
Muco-epidermoid carcinoma 3
Carcinoma ex pleomorphic adenoma 3
Acinic cell carcinoma 2
Metastatic lesions 2
Lymphoma 4
Table 2
DCE-MRI time intensity curve type detected in different parotid tumor.
Pathology No. of lesions on MRI
Pleomorphic adenoma 19
Warthin Tumor 21
Muco-epidermoid carcinoma 3
Carcinoma ex pleomorphic adenoma 3
Acinic cell carcinoma 2
Metastatic lesions 2
Lymphoma 4In our study, using type A curve on multiphasic CT as a
predictor for pleomorphic adenoma had high sensitivity,
specificity, positive and negative predictive values (100%,
94.3%, 90.5%, 100% respectively) (Fig. 2). Using type B curve
as a predictor for Warthin tumor also had high sensitivity,
specificity, positive and negative predictive values (85.7%,
100%, 100%, and 91.7% respectively) (Fig. 3). Using type C
curve as a predictor for malignancy also revealed high sen-
sitivity, specificity, positive and negative predictive values
(92.9%, 95%, 86.7%, and 97.4% respectively) (Fig. 4).
On dynamic MRI, type A curve was tested as a predictor
for pleomorphic adenoma, type B curve as a predictor for
Warthin tumor, and type C curve as a predictor for malig-
nancy. All revealed high sensitivity, specificity, positive
and negative predictive values (100%, 94.3%, 90.5%, 100%
for pleomorphic adenoma) (Fig. 2), (90.5%, 100%, 100%,
94.3% for Warthin tumor) (Fig. 3) and (92.9%, 97.5%,
92.9%, 97.5% for malignancy) (Fig. 4).
4. Discussion
Our study revealed that benign tumors are more com-
mon (representing 74%) than malignant tumors (repre-
senting 26%). These results are in agreement with a study
by Salama et al. [14] who found that benign tumors were
18 (72%) while the malignant tumors were 7 (28%). Gener-
ally, pleomorphic adenoma has been regarded as the most
common benign parotid gland tumor followed by Warthin
tumor [9,15]. The present study showed similar results
since there were 19 pleomorphic adenoma cases versus
14 Warthin tumor cases.
Here in the study, there was statistically significant dif-
ference between the age group having benign tumors
(average age 48.92 ± 10.75) and those having malignant
tumors (average age 57.07 ± 11.81), so malignant tumors
affected older age group. This is in agreement with Salama
et al. [14] who found that the mean age for benign tumors
was 46.23 years while for malignant tumors wasType A curve Type B curve Type C curve
19 – –
1 18 2
– – 3
– – 3
1 – 1
– – 2
– – 4
Type A curve Type B curve Type C curve
19 – –
1 19 1
– – 3
– – 3
1 – 1
– – 2
– – 4
Fig. 2. A 32-years-old man with right parotid gland pleomorphic adenoma. (a and b) Axial and coronal postcontrast CT showing ill-defined heterogeneously
enhancing lesion in the superficial lobe of the right parotid gland, and the lesion is separable from intra-parotid vessels. (c) Multiphasic dynamic CT with
density measurement and generation of time attenuation curve revealed progressive gradual enhancement similar to type A curve detected on dynamic
MRI. (d) Axial T2 weighted MRI showing that the lesion has well defined margin and high T2 SI. (e) Postcontrast MRI the lesion shows heterogeneous
enhancement. (f and g) Dynamic MRI with generation of TIC revealed that the lesion has type A curve with gradual progressive enhancement and TTP 177s.
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et al. [16] who reported that the mean age was higher in
malignant tumors (about 55 years) compared to benign
tumors (about 45 years).
The main significant limitations of MRI are that it could
not be done in patients having claustrophobia or with
internal ferromagnetic device. Also, it is a relatively costly
technique, long imaging time is required in some patients
and lacks definition of stones and calcification. On the
other hand, MRI demonstrates better soft tissue differenti-
ation [17]. CT findings including location, size, density,
bilateral occurrence, contour, intra-tumoral calcification,
or multiplicity are deficient in differentiating parotid gland
tumors. Previous studies indicated that the CT time atten-
uation curve could be valuable in the dynamic examination
of parotid tumors [18].
Yerli et al. [11] and Choi et al. [18] reported that pleo-
morphic adenomas enhance gradually and that delayed
enhancement is a powerful indicator of pleomorphic ade-
noma. Xu et al. [19] also found that all pleomorphic adeno-
mas in their study were enhanced gradually, in agreement
with previous reports. In the quantitative assessment, Öner
et al. [20] found that tumoral mean density numbers werehighest for Warthin tumors, followed by malignant
tumors, and then pleomorphic adenomas in early phase
scan. While tumoral mean density numbers were highest
for pleomorphic adenomas, followed by malignant tumors,
and then Warthin tumor in delayed phase scan. The time-
attenuation curves obtained in their study were corre-
sponding to the TICs of previous DCE-MRI studies [13].
Yerli et al. [11] reported that it is necessary to perform
the CT study of a parotid tumor as soon as possible, and
this is especially important with uncooperative patients.
In their study 4-phase dynamic CT images were acquired
at 30 s, 90 s, 5 min, and 25 min after contrast injection.
However, they found that routine 25-min scanning was
not practical, and it is more useful to evaluate parotid
gland tumor using only 3-phase dynamic CT (i.e., possible
peak enhancement time of 30 s, 90 s, and 5 min).
Our multiphasic CT study was performed by obtaining
images before contrast, then 30 s, 90 s, and 5 min after
contrast administration that allowed generation of time
attenuation curve similar to those described by dynamic
MRI. The results of our study were similar to the above
mentioned ones. The study found that pleomorphic
adenoma depicted gradual enhancement with peak
Fig. 3. A 54-years-old male patient with bilateral Warthin tumors. (a–c) Axial and coronal postcontrast CT revealed bilateral heterogeneously enhancing
lesions involving superficial lobe of the right parotid and both superficial and deep lobes of the left parotid gland. (d and e) Dynamic multiphasic CT with
density measurements and generation of time attenuation curve revealed that both lesions show early enhancement and rapid high washout similar to type
B curve detected on MRI. (f and g) Axial T1 weighted MRI showing that both lesions have mixed low and high SI on T1WI (notice that there is small left peri-
parotid LN). (h–j) Axial and coronal T2 WI also show that both lesions have mixed SI on T2 WI. (k and l) Postcontrast MRI demonstrating that both lesions
show heterogeneous enhancement. (m–p) Dynamic MRI show that both lesions have type B curve with early enhancement and rapid high washout >30%.
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ficity, positive and negative predictive values of 100%,
94.3%, 90.5%, and 100% respectively. Warthin tumorshowed rapid enhancement and high washout with sensi-
tivity, specificity, positive and negative predictive values of
85.7%, 100%, 100%, and 91.7% respectively. Malignant
Fig. 3 (continued)
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sensitivity, specificity, positive and negative predictive val-
ues of 92.9%, 95%, 86.7%, and 97.4% respectively.
Therefore time attenuation curve analysis on dynamic
multiphasic CT showed high sensitivity, specificity, posi-
tive predictive, negative predictive values and accuracy in
characterization of benign and malignant tumors (92.6%,
96.3%, 92.6%, 96.3%, and 95.1% respectively).
Regarding dynamic TIC we followed those described by
Yabuuchi et al. [13]. They analyzed TIC parameters and
found that, TTP closely correlated with micro-vessel count
and the Washout ratio (WR) reflected accurately the
cellularity-stromal grade. The micro-vessel count repre-
sents tumor vascularity, and thus TTP will be short when
the micro-vessel count is high. The WR relies upon the dif-
ference in the amount of the contrast material between the
intravascular and extravascular phases within the tumor.
Large extracellular space with fibrous stroma retains the
contrast material for a certain period. Thus, tumors with
high cellularity-stromal grade retain less contrast and have
a high WR. On the other hand, tumors with a low
cellularity-stromal grade will have a low WR.The long TTP for pleomorphic adenomas is consistent
with their low micro-vessel count and low cellularity-
stromal grade. The short TTP and high WR for Warthin
tumors reflected their high micro-vessel count and high
cellularity-stromal grade. The short TTP and low WR for
malignant tumors could be explained by their high
micro-vessel count and low cellularity-stromal grade [21].
According to a study by Yabuuchi et al. [13], TTP of
120 s allowed the differentiation between pleomorphic
adenomas and malignant tumors. On the other hand, eval-
uation of the TTP alone did not allow the differentiation
between Warthin tumors and malignant tumors. The
WRs for malignant tumors were significantly lower than
those for Warthin tumors. Therefore, the combined evalu-
ation of TTP and WR allowed the differentiation between
pleomorphic adenomas, Warthin tumors, and malignant
tumors. Therefore, TIC types classified according to TTP
and WR had high sensitivity and specificity in the charac-
terization of benign and malignant tumors.
El Shahat et al. [10] reported that pleomorphic adeno-
mas exhibited gradual enhancement pattern, (type A TIC),
Warthin tumors depicted an early peak of enhancement
Fig. 4. A 65-years-old female patient with left parotid mucoepidermoid carcinoma (a and b) axial and (c) coronal multi-slice postcontrast CT revealed
partially ill defined lesion in the superficial lobe of the left parotid gland, the lesion is partially solid and partially cystic, it is seen extending beyond the
gland with infiltration of the overlying subcutaneous fat and skin. The lesion shows heterogeneous enhancement, and the lesion is separable from
intraparotid vessels. (d) Dynamic multiphasic CT with density measurement and generation of time attenuation curve revealed early enhancement with
low delayed washout corresponding to type C curve on dynamic MRI. (e) Shows that the lesion has low SI on T1 weighted MRI (f and g) mixed SI is noted on
T2WI. (h–j) Axial and coronal postcontrast MRI the lesion shows heterogeneous enhancement of the solid component. (k and l) Dynamic MRI revealed type
C curve with TTP = 25 s and low washout <30%.
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tumors depicted an early peak of enhancement and a low
washout pattern, (type C TIC).
Our study revealed similar results since, type A TIC was
tested as a predictor for pleomorphic adenoma, type B TIC
as a predictor for Warthin tumor, and type C TIC as a pre-
dictor for malignancy. All revealed high sensitivity, speci-ficity, positive and negative predictive values as follows:
100%, 94.3%, 90.5%, 100% for pleomorphic adenoma,
90.5%, 100%, 100%, 94.3% for Warthin tumor and 92.9%,
97.5%, 92.9%, 97.5% for malignancy.
Eissa et al. [9] tested type C curve as a predictor of
malignancy against other types of TICs. But their study
had a lower validation results (moderate 63% sensitivity
Fig. 4 (continued)
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58%, and high negative predictive value of 89.7%).
Yabuuchi et al. [13] found that the sensitivity, speci-
ficity, negative predictive value, positive predictive value,
and accuracy of TIC-based tumor differentiation were
91%, 91%, 95%, 83%, and 91% respectively. Our study
revealed higher validation study of TIC-based tumor differ-
entiation with high sensitivity, specificity, positive predic-
tive, negative predictive values and accuracy (94.4%, 97.2%,
94.4%, 97.2%, and 96.3% respectively).
Eida et al. [22] found few malignant lesions exhibiting
type A curve. This was in accordance with Eissa et al’s [9]
study in which they found a single malignant case of carci-
noma ex-pleomorphic adenoma showing type A curve.Similar results were obtained in our study since we had a
case of acinic cell carcinoma that showed type A curve.
Again Eida et al. [22] found lesions with type C curve were
all malignant. This is contradictory to those by Yabuuchi
et al. [23] and Eissa et al. [9] since this curve was exhibited
by few pleomorphic adenomas. Also our study revealed
Warthin tumor lesions (one on DCE-MRI and two on mul-
tiphasic CT) having type C curve.
Eida et al. [22] and Eissa et al. [9] reported that type B
curve predominate in Warthin tumors and lymphomas.
Our study revealed similar results as regards Warthin
tumor but was contradictory as regards lymphoma which
exhibited type C curve in our study. This could be sup-
ported by a study by Yabuuchi et al. [13] that included 2
1372 M. Metwally Abo El Atta et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1361–1372cases of lymphoma: one of them showed type C curve and
the other showed type B curve.
Ikeda et al. [15] stated that epithelial stroma and lym-
phoid tissue with small slit like cysts seen in Warthin
tumors exhibited early enhancement and a high washout
rate (>30%) on dynamic contrast enhanced studies, and
accumulation of complicated cysts exhibited early
enhancement and low washout ratio (<30%). The average
washout ratio of Warthin tumors was significantly higher
than that of malignant tumors. This could explain the case
of Warthin tumor in our study that showed type C curve.
5. Conclusion
Our study concluded that multiphasic CT with images
obtained before contrast, then at 30 s, 90 s, and 5 min after
contrast administration with generation of time attenua-
tion curve had comparable high sensitivity, specificity,
and accuracy to TIC on DCE-MRI in characterizing different
histologic types of parotid gland tumors.
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